# Effects of Levosimendan on Microcirculation in Septic Shock

> **NCT00800306** · PHASE2 · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 40 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** dobutamine

## Key facts

- **NCT ID:** NCT00800306
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-02
- **Final completion:** 2009-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2009-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800306, "Effects of Levosimendan on Microcirculation in Septic Shock". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00800306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*